Soleil Securities Maintains a Buy Rating on Varian Medical (VAR), Lowers Price Target
Tweet Send to a Friend
Soleil Securities maintains a Buy rating on Varian Medical Systems (NYSE: VAR). Price target lowered from $63 to $53.
This article: 114 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 114 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


